329 related articles for article (PubMed ID: 25047851)
1. Fat metaplasia and backfill are key intermediaries in the development of sacroiliac joint ankylosis in patients with ankylosing spondylitis.
Maksymowych WP; Wichuk S; Chiowchanwisawakit P; Lambert RG; Pedersen SJ
Arthritis Rheumatol; 2014 Nov; 66(11):2958-67. PubMed ID: 25047851
[TBL] [Abstract][Full Text] [Related]
2. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.
Pedersen SJ; Weber U; Said-Nahal R; Sørensen IJ; Loft AG; Kollerup G; Juul L; Frandsen PB; Thamsborg G; Madsen OR; Møller J; Balding L; Jurik AG; Østergaard M
Scand J Rheumatol; 2019 May; 48(3):185-197. PubMed ID: 30422733
[TBL] [Abstract][Full Text] [Related]
3. Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.
Pedersen SJ; Poddubnyy D; Sørensen IJ; Loft AG; Hindrup JS; Thamsborg G; Asmussen K; Hendricks O; Nørregaard J; Piil AD; Møller JM; Jurik AG; Balding L; Lambert RG; Sieper J; Østergaard M
Arthritis Rheumatol; 2016 Feb; 68(2):418-29. PubMed ID: 26414004
[TBL] [Abstract][Full Text] [Related]
4. Fat metaplasia on MRI of the sacroiliac joints increases the propensity for disease progression in the spine of patients with spondyloarthritis.
Maksymowych WP; Wichuk S; Chiowchanwisawakit P; Lambert RG; Pedersen SJ
RMD Open; 2017; 3(1):e000399. PubMed ID: 28469937
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.
Pedersen SJ; Wichuk S; Chiowchanwisawakit P; Lambert RG; Maksymowych WP
Arthritis Res Ther; 2014 Apr; 16(2):R100. PubMed ID: 24755322
[TBL] [Abstract][Full Text] [Related]
6. Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
Maksymowych WP; Østergaard M; Landewé R; Barchuk W; Liu K; Tasset C; Gilles L; Hendrikx T; Besuyen R; Baraliakos X
Rheumatology (Oxford); 2022 May; 61(5):2063-2071. PubMed ID: 34352069
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
[TBL] [Abstract][Full Text] [Related]
8. Development and preliminary validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging sacroiliac joint structural score.
Maksymowych WP; Wichuk S; Chiowchanwisawakit P; Lambert RG; Pedersen SJ
J Rheumatol; 2015 Jan; 42(1):79-86. PubMed ID: 25320219
[TBL] [Abstract][Full Text] [Related]
9. Baseline Severity of Sacroiliitis and Extensive Fat Metaplasia Predicts the Progression of Backfill at the Sacroiliac Joint in Patients With Axial Spondyloarthritis.
Zhang Y; Guo Z; Wang L; Zhan Y; Qu J; Lei X
Front Immunol; 2022; 13():887470. PubMed ID: 35833133
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of 3 Preliminary MRI Sacroiliac Joint Composite Structural Damage Scores in a 5-year Longitudinal Axial Spondyloarthritis Study.
Wetterslev M; Østergaard M; Sørensen IJ; Weber U; Loft AG; Kollerup G; Juul L; Thamsborg G; Madsen OR; Møller JM; Pedersen SJ
J Rheumatol; 2021 Oct; 48(10):1537-1546. PubMed ID: 33858979
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and Reliability of the Spondyloarthritis Research Consortium of Canada Sacroiliac Joint Structural Score in Children.
Weiss PF; Maksymowych WP; Lambert RG; Jaremko JL; Biko DM; Paschke J; Brandon TG; Xiao R; Chauvin NA
J Rheumatol; 2018 Oct; 45(10):1411-1417. PubMed ID: 29907669
[TBL] [Abstract][Full Text] [Related]
12. MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.
Maksymowych WP; Wichuk S; Dougados M; Jones H; Szumski A; Bukowski JF; Marshall L; Lambert RG
Arthritis Res Ther; 2017 Jun; 19(1):126. PubMed ID: 28587658
[TBL] [Abstract][Full Text] [Related]
13. The value of SPARCC sacroiliac MRI scoring in axial psoriatic arthritis and its association with other disease parameters.
Gezer HH; Duruöz MT
Int J Rheum Dis; 2022 Apr; 25(4):433-439. PubMed ID: 35080124
[TBL] [Abstract][Full Text] [Related]
14. Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing Spondylitis.
Maksymowych WP; Lambert RG; Brown LS; Pangan AL
J Rheumatol; 2012 Aug; 39(8):1666-74. PubMed ID: 22753648
[TBL] [Abstract][Full Text] [Related]
15. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Baraliakos X; Lambert RG; Landewé R; Sandoval D; Carlier H; Lisse J; Li X; Hojnik M; Østergaard M
Lancet Rheumatol; 2022 Sep; 4(9):e626-e634. PubMed ID: 38288892
[TBL] [Abstract][Full Text] [Related]
16. Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Wichuk S; Dougados M; Jones HE; Pedersen R; Szumski A; Marshall L; Bukowski JF; Lambert RG
Ann Rheum Dis; 2018 Jan; 77(1):78-84. PubMed ID: 28970212
[TBL] [Abstract][Full Text] [Related]
17. Imaging in Axial Spondyloarthritis: Evaluation of Inflammatory and Structural Changes.
Maksymowych WP
Rheum Dis Clin North Am; 2016 Nov; 42(4):645-662. PubMed ID: 27742019
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.
Lambert RG; Salonen D; Rahman P; Inman RD; Wong RL; Einstein SG; Thomson GT; Beaulieu A; Choquette D; Maksymowych WP
Arthritis Rheum; 2007 Dec; 56(12):4005-14. PubMed ID: 18050198
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trial.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Freundlich B; Lange E; Rudwaleit M; Sieper J
Semin Arthritis Rheum; 2016 Feb; 45(4):404-10. PubMed ID: 26519007
[TBL] [Abstract][Full Text] [Related]
20. Fat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis.
Kang KY; Kim IJ; Yoon MA; Hong YS; Park SH; Ju JH
PLoS One; 2015; 10(8):e0135206. PubMed ID: 26271099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
